Cargando…

Medication counselling with sodium glucose transporter 2 inhibitor therapy

Detalles Bibliográficos
Autores principales:	Kalra, Sanjay, Baruah, Manash P., Sahay, Rakesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171879/ https://www.ncbi.nlm.nih.gov/pubmed/25285273 http://dx.doi.org/10.4103/2230-8210.139206

Ejemplares similares

Erratum to: Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
por: Kalra, Sanjay, et al.
Publicado: (2016)

Metformin + Sodium-glucose Co-transporter-2 Inhibitor: Salutogenic Lifestyle Mimetics in a Tablet?
por: Kalra, Sanjay, et al.
Publicado: (2018)

Person centered care in the Second Diabetes Attitudes, Wishes and Needs (DAWN2) study: Inspiration from India
por: Kalra, Sanjay, et al.
Publicado: (2014)

Health economics in India: The case of diabetes mellitus
por: Sahay, Rakesh, et al.
Publicado: (2014)

From humans to giraffes: The evolution of hypertension and hormones
por: Kalra, Sanjay, et al.
Publicado: (2011)

Pentads and Hexads in Diabetes Care: Numbers as Targets; Numbers as Tools
por: Kalra, Sanjay, et al.
Publicado: (2017)

Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis
por: Kalra, Sanjay, et al.
Publicado: (2015)

Comparative Efficacy and Safety Among Sodium-glucose Cotransporter-2 Inhibitors in Type 2 Diabetes – Results from a Retrospective Single-centre Study
por: Baruah, Manash P, et al.
Publicado: (2019)

Salutogenesis in Type 2 Diabetes Care: A Biopsychosocial Perspective
por: Kalra, Sanjay, et al.
Publicado: (2018)

Sodium-glucose Cotransporter 2 Inhibitor Use: A Pharmaco-ergonomic Qualification Tool
por: Kalra, Sanjay, et al.
Publicado: (2017)

Sodium Glucose Co-transporter-2 Inhibitor: Benefits beyond Glycemic Control
por: Baruah, Manash Pratim, et al.
Publicado: (2019)

Diabetes therapy by the ear
por: Kalra, Sanjay, et al.
Publicado: (2013)

Interaction, Information, Involvement (The 3I strategy): Rebuilding Trust in the Medical Profession
por: Kalra, Sanjay, et al.
Publicado: (2017)

The history of parathyroid endocrinology
por: Kalra, Sanjay, et al.
Publicado: (2013)

Diabetes therapy by the ear: A bi-directional process
por: Kalra, Sanjay, et al.
Publicado: (2015)

Publication trends in the Indian Journal of Endocrinology and Metabolism
por: Kalra, Sanjay, et al.
Publicado: (2011)

Patient centred approach in endocrinology: From introspection to action
por: Baruah, Manash P, et al.
Publicado: (2012)

Diabetes Care: Evolution of Philosophy
por: Kalra, Sanjay, et al.
Publicado: (2017)

Metformin; A character actor in the leptin story!
por: Baruah, Manash P., et al.
Publicado: (2012)

Trends in endocrine onomastics: The case of polycystic ovarian syndrome
por: Kalra, Sanjay, et al.
Publicado: (2013)

Can cardiac autonomic neuropathy be a predictor of cardiovascular outcomes in diabetes?
por: Kalra, Sanjay, et al.
Publicado: (2015)

Metabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease
por: Kalra, Sanjay, et al.
Publicado: (2021)

Celebrating life with Rita Levi-Montalcini: A hundred years and more
por: Kalra, Sanjay, et al.
Publicado: (2012)

Endocrine hypertension: Changing paradigm in the new millennium
por: Baruah, Manash P., et al.
Publicado: (2011)

Hypothyroidism in pregnancy: From unanswered questions to questionable answers
por: Kalra, Sanjay, et al.
Publicado: (2013)

Responsible Patient-centered Care
por: Kalra, Sanjay, et al.
Publicado: (2017)

The other insulin story of 1921
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2011)

Safe and pragmatic use of sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement
por: Kalra, Sanjay, et al.
Publicado: (2017)

Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and future
por: Kalra, Sanjay, et al.
Publicado: (2016)

Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology
por: Kalra, Sanjay
Publicado: (2014)

Erratum to: Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology
por: Kalra, Sanjay
Publicado: (2015)

Therapeutic Experience of Saxagliptin as First Add-on after Metformin in Indian Type 2 Diabetes Patients: A Non-interventional, Prospective, Observational Study (ONTARGET-INDIA)
por: Kalra, Sanjay, et al.
Publicado: (2019)

Transgenerational Karma
por: Kalra, Bharti, et al.
Publicado: (2017)

Short-term outcomes of type 2 diabetes mellitus patients treated with canagliflozin in real-world setting
por: Baruah, Manash P., et al.
Publicado: (2016)

Renaming gestational diabetes mellitus: A psychosocial argument
por: Kalra, Bharti, et al.
Publicado: (2013)

Incorporating Integrated Personalised Diabetes Management (iPDM) in Treatment Strategy: A Pragmatic Approach
por: Kalra, Sanjay, et al.
Publicado: (2022)

An acute need for awareness of insulin injection guidelines in operative and intensive care units
por: Bajwa, Sukhminder Jit Singh, et al.
Publicado: (2013)

Timely insulin use: Need for social marketing
por: Kalra, Sanjay, et al.
Publicado: (2016)

Diabetes Fatigue Syndrome
por: Kalra, Sanjay, et al.
Publicado: (2018)

Sodium-Glucose Co-transporter 2 Inhibitor: The Magic Bullet for Obesity in Diabetes?
por: Seo, Ji A
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cpbjmiebect4n97dilh64p5fkt